regeneron vice president salary
Sing has extensive venture capital and leadership experience in the biotechnology sector. He previously served as the regional CFO for Japan, Australia and New Zealand at Mylan, as well as other roles, and he worked at Cephalon in financial roles. VA. As a member of AAMVA's Human Resources team, the position is responsible for managing and coordinating areas of Human Resources and Office Management to include but not limited to compliance ZipRecruiter ATS Jobs for ZipSearch/ZipAlerts - 5 days ago. Dr. DiCioccio leads a team for four integrated functions: Preclinical & Translation PK/PD, and clinical and quantitative pharmacology with supporting efforts from a group of data scientists. Ms. McCourt began her career and spent 12 years at AstraZeneca, ultimately becoming chief operating officer for AstraZeneca U.S. She received her B.S. from Boston College and a B.A. We encourage you to read the privacy policy of every website you visit. Co-Founder, President and Chief Executive Officer, Co-Founder, President and Chief Scientific Officer, Senior Vice President, Financial Planning and Analysis. Based on 12 salaries posted anonymously by AstraZeneca Vice President Finance employees in Seaham, England. The highest-paying job at Regeneron is a Senior Director with a salary of $376,244 per year. Regental Professor of Molecular Genetics and Internal Medicine, Director, Erik JonssonCenter for Molecular Genetics, The University of Texas Southwestern Medical Center at Dallas. In addition, his team oversees regulatory functions including labeling and advertising/promotion and compliance. Prior to joining Regeneron, Mr. Calabro spent 18 years at UST, Inc., where he held positions of increasing responsibility within internal audit, ultimately serving as director of internal. Senior Vice President, Drug Safety and Pharmacometrics. He holds a B.S. Dr. Tessier-Lavigne has been a director of the company since 2011. Please enable Cookies and reload the page. Dr. Sirulnik is a licensed physician, formerly practicing at Dana-Farber Cancer Institute and Brigham and Womens Hospital and was a fellow in hematology/oncology at Mount Sinai Health System. Senior Vice President, Development Operations and Portfolio Management. , Senior Vice President, Regeneron Genetics Center. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. He previously held various leadership positions in the biopharmaceutical and pharmaceutical industries, including at Merck & Co., Inc., Bristol-Myers Squibb Company and Vertex Pharmaceuticals Incorporated. Related Searches:All Vice President Salaries|All Regeneron Salaries. and M.D. Chief Diversity, Equity and Inclusion Officer. 46 Regeneron Pharmaceuticals average salary is $95,435, median salary is $87,381 with a salary range from $41,600 to $373,100. and Ph.D. in chemical engineering from the University of Virginia. in chemical engineering from the University of Nevada, Reno and his Ph.D. in chemical engineering from Iowa State University. from the Aristotle University of Thessaloniki in Greece and then received his Ph.D. in microbiology at Columbia University. Dr. Yancopoulos, together with key members of his team, is a principal inventor and/or developer of the nine FDA-approved drugs Regeneron has developed: EYLEA (aflibercept) Injection, Praluent (alirocumab), Dupixent (dupilumab), Kevzara (sarilumab), Libtayo (cemiplimab), EvkeezaTM (evinacumab-dgnb), Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn), ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST (rilonacept) Injection for Subcutaneous Use, as well as Regeneron's foundation technologies, including the TRAP technology, VelociGene and VelocImmune. Average salary for AstraZeneca Vice President Finance in Seaham, England: [salary]. Find high paying available jobs at Regeneron Pharmaceuticals, Inc.For expert network information on Regeneron Pharmaceuticals, Inc compensation and careers, use Ladders $100K + Club. Maya Bermingham, J.D., joined Regeneron in 2015 and serves as senior vice president, public policy and government affairs. from the University of Navarra, completed a fellowship in immunology/pulmonary and critical care at Yale University, received an MPH. She received her B.S. Prior to this role, he was senior vice president, late stage clinical development and medical affairs. Christine Childrose joined Regeneron in 2014 and serves as senior vice president, IOPS human resources and HR Operations. Prior to Regeneron, Dr. Akinlade held medical director roles of increasing seniority at Astellas Pharma and Abbott Laboratories (now AbbVie). $2.8M. Prior to joining Regeneron, Mr. Yocum worked within the Chemistry Department at Seattle Pacific University. Zoran Berkovic joined Regeneron in 2017 and is senior vice president, financial planning & analysis, where he has grown the scope of the group and fostered a culture of accountability. from Cornell University and a J.D. She started her career at Regeneron as a research engineer working in the purification development group within PMPD and has subsequently held roles of increasing responsibility. These charts show the average base salary (core compensation), as well as the average total cash compensation for Vice President of Human Resources in companies like REGENERON PHARMACEUTICALS, INC. in the United States. Made up of our founding scientists, industry experts, Nobel Laureates and members of the National Academy of Sciences, we consistently push the boundaries of scientific excellence and discovery. Before joining Regeneron, Dr. Sirulnik was chief medical officer at Merus N.V., a clinical-stage immuno-oncology company. Kerry Reinertsen, Ph.D., joined Regeneron in 2011 and serves as senior vice president of strategic alliances. Senior Vice President, Manufacturing and Process Sciences. Disculpa She holds a B.S. Prior to that, Dr. Herman completed his residency and postdoctoral training at University of California, San Francisco and was an assistant professor there before joining industry. The VP of Programs will be expected to collaborate onsite with team members and staff. In addition to a robust portfolio of antibody therapeutics, she has been a company leader in the application of novel nucleotide and gene therapies. from the University of Wisconsin-Madison and his Ph.D. from the University of Washington. from Hibernia College. , Average salary for GSK Vice President Human Resources in Skelmersdale, England: [salary]. As Executive Vice President, Research at REGENERON PHARMACEUTICALS, INC., Andrew J. Murphy Ph.D. made $7,146,830 in total compensation. At Regeneron, we believe in the power of original thinking. The charts on this page feature a breakdown of the total annual pay for the top executives at REGENERON PHARMACEUTICALS, INC. as reported in their proxy statements. In addition, he was a former director of Laboratory Corporation of America Holdings, Campus Crest Communities, Inc., CRISPR Therapeutics AG, and McKesson Corporation. Be the first to add REGENERON PHARMACEUTICALS, INC. Vice President of Human Resources responsibilities. If you continue to see this Mr. Fenimore is a Certified Public Accountant in the state of New York. Other. Dr. Weinreich received his B.S. Executive Vice President, Global Clinical Development. at the State University of New York at Albany and a J.D. Before joining Regeneron, he was at Progenics Pharmaceuticals for 19 years. He is a physician-scientist with decades of experience in design, execution and analysis of clinical trials. Prior to that she was chief diversity officer for Dow Jones, including its flagship brand, The Wall Street Journal. The estimated total pay for a Vice President at Regeneron is $419,353 per year. Christina Chan joined Regeneron in 2021 and serves as senior vice president, corporate communications and citizenship, leading a multidisciplinary team responsible for external & internal communication, patient advocacy, corporate responsibility, ESG strategy & reporting, and social impact. Gang Chen, Ph.D., is the head of protein expression sciences (PES) in his role as senior vice president. Frederick Austin joined Regeneron in 2012 and serves as senior vice president, quality control, Raheen. questo messaggio, invia un'email all'indirizzo Bola Akinlade, M.D., FACP, joined Regeneron in 2015 and serves as senior vice president, clinical development for Regenerons immunology and inflammation (I&I) portfolio. Mr. Brooks leads a team responsible for optimizing liquidity and use of capital resources, safeguarding Regenerons cash and investment portfolio, corporate risk management and maintaining strong relationships with financial institutions, insurance providers and rating agencies. Dr. Macdonald is responsible for heading the VelocImmune-NEXT technology development group, neuroscience group, molecular profiling & data sciences group, and DNA core & Aautomation group. CA. Prior to joining Regeneron, she worked at Raytheon Engineers & Construction, Genzyme Corporation and Repligen Corporation. in marketing at Auburn University and his MBA at New York University. He has been the president of Stanford University since 2016. Senior Vice President, Clinical Sciences General Medicine. Know Your Worth. Salary.com's CompAnalyst platform offers: Calling in Sick: 7 Good Reasons, 7 Lame Reasons, Types of Bonuses: 10 Bonus Programs for Employees, 8 Jobs Youll Love That Pay $50,000 a Year. Overall Benefits Rating.css-11cfy92{color:#0caa41 !important;}.css-11cfy92{color:#0caa41 !important;}4.1, Matches half of your contribution up to 5% (of gross pay) on 10%. at Saint Johns University. Dr. Thompson is a member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the Association of American Physicians. Drs. She oversees global HR systems and processes and is expanding HR operations to support employees in a growing number of countries outside the U.S. Regeneron employees rate the overall compensation and benefits package 4.2/5 stars. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. The community relies on everyone sharing. The information shown here is a reporting of information included in the company's proxy statement. Mr. Calabro leads a team responsible for providing independent and objective assurance and consulting by bringing a systematic, disciplined approach to evaluating and improving the effectiveness of Regenerons risk management, control and governance processes.